SIMETHICONE 180MG USP 180 MG — DIN 02247661
SIMETHICONE : 180 MG · PHARMA STRIDES CANADA CORPORATION · CAPSULE · wholesale supply in Canada
Health Canada status: CANCELLED (UNRETURNED ANNUAL)
What is SIMETHICONE 180MG USP?
SIMETHICONE 180MG USP 180 MG contains SIMETHICONE : 180 MG. It is listed in the Health Canada Drug Product Database under DIN 02247661, held by PHARMA STRIDES CANADA CORPORATION, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled (unreturned annual), status dated 22-Oct-2021. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Silicones in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
31 holders have a Canadian DIN containing Silicones, across 53 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| CHURCH & DWIGHT CANADA CORP | 4 | 4 | OVOL DROPS, OVOL FOR GAS 180 MG CAPSULE, OVOL FOR GAS 180 MG TABLET, OVOL FOR GAS 80 MG TABLET | Sourceable in Canada |
| HALEON CANADA ULC | 2 | 2 | GAS X ULTRA STRENGTH, GAS-X EXTRA STRENGTH | Sourceable in Canada |
| C B FLEET COMPANY INC | 2 | 1 | PHAZYME CAP 125MG, ULTRA STRENGTH PHAZYME 180MG SOFTGELS | Sourceable in Canada |
| EURO-PHARM INTERNATIONAL CANADA INC | 1 | 1 | PEDIACOL | Sourceable in Canada |
| GUARDIAN DRUG COMPANY INC | 1 | 1 | GAS RELIEF TABLETS | Sourceable in Canada |
| VITA HEALTH PRODUCTS INC | 1 | 1 | ULTRA STRENGTH GAS RELIEF | Sourceable in Canada |
| GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC | 5 | 0 | GAS X THIN STRIPS 62.5MG SIMETHICONE, GAS-X REGULAR STRENGTH, PHAZYME CAP 95MG, TUMS GAS RELIEF 125 MG, TUMS GAS RELIEF STRONG 180 MG | No marketed DIN |
| NOVARTIS CONSUMER HEALTH CANADA INC. | 4 | 0 | EXTRA STRENGTH MAALOX GRF TABLETS 150MG, GAS-X SUPER EXTRA STRENGTH, GERBER GAS RELIEF DROPS, MAALOX GRF TABLETS 80MG | No marketed DIN |
| CARTER-HORNER CORP. | 3 | 0 | OVOL 160MG CHEWABLE TABLETS, OVOL TABLETS 40MG CHEWABLE, OVOL-95 MG CAPSULES | No marketed DIN |
| BANNER PHARMACAPS (CANADA) LTD. | 2 | 0 | GAS RELIEF, ULTRA STRENGTH GAS RELIEF | No marketed DIN |
| CATALENT ONTARIO LIMITED | 2 | 0 | EXTRA STRENGTH GAS RELIEF LIQUID GELS, GAS RELIEF LIQUID GELS | No marketed DIN |
| CELLCHEM PHARMACEUTICALS INC. | 2 | 0 | SIMETHICONE 125 MG SOFTGEL CAPSULES, SIMETHICONE 180 MG SOFTGEL CAPSULES | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 180 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Silicones |
|---|---|
| ATC code | A03AX13 |
| AHFS class | 56:10.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02247661 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2247661 |
| Brand name | SIMETHICONE 180MG USP |
| Generic / active ingredient | SIMETHICONE : 180 MG |
| Market authorization holder | PHARMA STRIDES CANADA CORPORATION |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A03AX13 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A03AX |
| Current status | CANCELLED (UNRETURNED ANNUAL) |
| Status date | 22-Oct-2021 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 53 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| GAS RELIEF TABLETS | 125 MG | TABLET (CHEWABLE) | GUARDIAN DRUG COMPANY INC | MARKETED | 02328127 |
| GAS X ULTRA STRENGTH | 180 MG | CAPSULE | HALEON CANADA ULC | MARKETED | 02300761 |
| GAS-X EXTRA STRENGTH | 125 MG | TABLET (CHEWABLE) | HALEON CANADA ULC | MARKETED | 00896675 |
| OVOL DROPS | 40 MG | DROPS | CHURCH & DWIGHT CANADA CORP | MARKETED | 00013617 |
| OVOL FOR GAS 180 MG CAPSULE | 180 MG | CAPSULE | CHURCH & DWIGHT CANADA CORP | MARKETED | 02239298 |
| OVOL FOR GAS 180 MG TABLET | 180 MG | TABLET | CHURCH & DWIGHT CANADA CORP | MARKETED | 02247127 |
| OVOL FOR GAS 80 MG TABLET | 80 MG | TABLET | CHURCH & DWIGHT CANADA CORP | MARKETED | 00292990 |
| PEDIACOL | 40 MG | DROPS | EURO-PHARM INTERNATIONAL CANADA INC | MARKETED | 02245510 |
| ULTRA STRENGTH GAS RELIEF | 180 MG | CAPSULE | VITA HEALTH PRODUCTS INC | MARKETED | 02244204 |
| ULTRA STRENGTH PHAZYME 180MG SOFTGELS | 180 MG | CAPSULE | C B FLEET COMPANY INC | MARKETED | 02237698 |
2 · Same class — other molecules in ATC A03AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Silicones | BABY'S OWN COLIC DROPS 40MG/ML · BABY'S OWN INFANT DROPS - 40MG/0.6ML · CANCAP SIMETHICONE USP 180 MG SOFT CAPSULES · CHEWABLE EXTRA STRENGTH GAS RELIEF · +46 more | 53 | 10 | Yes |
| Pinaverium | DICETEL · PINAVERIUM | 4 | 4 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A03A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A03AB | Glycopyrronium · Propantheline | 18 | 8 |
| A03AA | Dicycloverine · Dicycloverine, Combinations · Trimebutine | 24 | 7 |
| A03AD | Papaverine | 1 | 1 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled (unreturned annual) in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.